No.,Title,Link
1,Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0920-3
2,Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0917-y
3,Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0918-x
4,Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0916-z
5,Positive association between baseline brachial–ankle pulse wave velocity and the risk of new-onset diabetes in hypertensive patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0915-0
6,Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0912-3
7,Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0913-2
8,Successful revascularization versus medical therapy in diabetic patients with stable right coronary artery chronic total occlusion: a retrospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0911-4
9,Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0914-1
10,Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0910-5
11,The association between serum adiponectin and 3-month outcome after ischemic stroke,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0908-z
12,High-intensity interval training improves metabolic syndrome and body composition in outpatient cardiac rehabilitation patients with myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0907-0
13,Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0909-y
14,A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0906-1
15,Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0905-2
16,Insulin resistance and dysglycemia are associated with left ventricular remodeling after myocardial infarction in non-diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0904-3
17,Class effects of SGLT2 inhibitors on cardiorenal outcomes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0903-4
18,Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0902-5
19,Novel associations between sex hormones and diabetic vascular complications in men and postmenopausal women: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0901-6
20,Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0900-7
21,Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0898-x
22,Class effect for SGLT-2 inhibitors: a tale of 9 drugs,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0899-9
23,Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0897-y
24,Depressed systemic arterial compliance and impaired left ventricular midwall performance in aortic stenosis with concomitant type 2 diabetes: a retrospective cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0894-1
25,GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0896-z
26,Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0895-0
27,Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0893-2
28,The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0891-4
29,"A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0890-5
30,Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0892-3
31,Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0889-y
32,"Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0887-0
33,Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0886-1
34,Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0888-z
35,"Relationship between frailty and mortality, hospitalization, and cardiovascular diseases in diabetes: a systematic review and meta-analysis",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0885-2
36,New dual peroxisome proliferator activated receptor agonist—Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0884-3
37,Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0883-4
38,Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0879-0
39,Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0882-5
40,"Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0871-8
41,Canagliflozin for Japanese patients with chronic heart failure and type II diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0877-2
42,Good glycemic control of gestational diabetes mellitus is associated with the attenuation of future maternal cardiovascular risk: a retrospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0881-6
43,Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0880-7
44,Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0870-9
45,The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0864-7
46,Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0875-4
47,"Impact of serum 1,5-anhydro-d-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0878-1
48,Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0876-3
49,Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0874-5
50,Impact of hyperglycemia on myocardial ischemia–reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0872-7
51,Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0920-3
52,Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0917-y
53,Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0918-x
54,Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0916-z
55,Positive association between baseline brachial–ankle pulse wave velocity and the risk of new-onset diabetes in hypertensive patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0915-0
56,Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0912-3
57,Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0913-2
58,Successful revascularization versus medical therapy in diabetic patients with stable right coronary artery chronic total occlusion: a retrospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0911-4
59,Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0914-1
60,Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0910-5
61,The association between serum adiponectin and 3-month outcome after ischemic stroke,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0908-z
62,High-intensity interval training improves metabolic syndrome and body composition in outpatient cardiac rehabilitation patients with myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0907-0
63,Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0909-y
64,A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0906-1
65,Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0905-2
66,Insulin resistance and dysglycemia are associated with left ventricular remodeling after myocardial infarction in non-diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0904-3
67,Class effects of SGLT2 inhibitors on cardiorenal outcomes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0903-4
68,Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0902-5
69,Novel associations between sex hormones and diabetic vascular complications in men and postmenopausal women: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0901-6
70,Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0900-7
71,Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0898-x
72,Class effect for SGLT-2 inhibitors: a tale of 9 drugs,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0899-9
73,Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0897-y
74,Depressed systemic arterial compliance and impaired left ventricular midwall performance in aortic stenosis with concomitant type 2 diabetes: a retrospective cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0894-1
75,GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0896-z
76,Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0895-0
77,Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0893-2
78,The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0891-4
79,"A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0890-5
80,Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0892-3
81,Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0889-y
82,"Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0887-0
83,Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0886-1
84,Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0888-z
85,"Relationship between frailty and mortality, hospitalization, and cardiovascular diseases in diabetes: a systematic review and meta-analysis",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0885-2
86,New dual peroxisome proliferator activated receptor agonist—Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0884-3
87,Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0883-4
88,Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0879-0
89,Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0882-5
90,"Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0871-8
91,Canagliflozin for Japanese patients with chronic heart failure and type II diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0877-2
92,Good glycemic control of gestational diabetes mellitus is associated with the attenuation of future maternal cardiovascular risk: a retrospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0881-6
93,Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0880-7
94,Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0870-9
95,The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0864-7
96,Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0875-4
97,"Impact of serum 1,5-anhydro-d-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0878-1
98,Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0876-3
99,Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0874-5
100,Impact of hyperglycemia on myocardial ischemia–reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0872-7
101,Association of haptoglobin phenotype with incident acute myocardial infarction in Chinese patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0867-4
102,The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0869-2
103,The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0873-6
104,"Association of C2, a derivative of the radial artery pressure waveform, with new onset of type 2 diabetes mellitus: the MESA study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0868-3
105,Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0865-6
106,Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical mitral valve replacement in Spain (2001–2015),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0866-5
107,Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0856-7
108,Coronary plaque characteristics and epicardial fat tissue in long term survivors of type 1 diabetes identified by coronary computed tomography angiography,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0861-x
109,Elevated triglycerides rather than other lipid parameters are associated with increased urinary albumin to creatinine ratio in the general population of China: a report from the REACTION study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0863-8
110,Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the Strong Heart Study cohort,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0862-9
111,Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0857-6
112,Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0860-y
113,The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0859-4
114,"Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0858-5
115,Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0855-8
116,Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0854-9
117,Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0850-0
118,Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0851-z
119,"Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0853-x
120,"Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0852-y
121,The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0849-6
122,How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0839-8
123,Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case–control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0846-9
124,"Cardiovascular events, diabetes and guidelines: the virtue of simplicity",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0844-y
125,Comparison of outcomes after carotid endarterectomy between type 2 diabetic and non-diabetic patients with significant carotid stenosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0848-7
126,The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0847-8
127,Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0829-x
128,Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0845-x
129,Left ventricular concentric geometry predicts incident diabetes mellitus independent of established risk factors in the general population: the Copenhagen City Heart Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0842-0
130,Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0838-9
131,Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0843-z
132,Effects of combined training with different intensities on vascular health in patients with type 2 diabetes: a 1-year randomized controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0840-2
133,Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0837-x
134,Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0841-1
135,Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0836-y
136,Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0822-4
137,Clinical factors associated with the recovery of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0830-4
138,Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0835-z
139,Impact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0831-3
140,Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0832-2
141,Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0827-z
142,Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0826-0
143,Correction to: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0825-1
144,Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0833-1
145,Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0823-3
146,"Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0828-y
147,Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0834-0
148,Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0824-2
149,sRAGE and early signs of cardiac target organ damage in mild hypertensives,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0821-5
150,SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0820-6
151,SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0816-2
152,"Comparative effects of lipid lowering, hypoglycemic, antihypertensive and antiplatelet medications on carotid artery intima-media thickness progression: a network meta-analysis",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0817-1
153,Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0814-4
154,Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0818-0
155,Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0819-z
156,PDM-ProValue meets cardiovascular outcome trials in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0815-3
157,Developmental trajectories of body mass index from childhood into late adolescence and subsequent late adolescence–young adulthood cardiometabolic risk markers,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0813-5
158,Association between serum haptoglobin and carotid arterial functions: usefulness of a targeted metabolomics approach,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0808-2
159,MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0811-7
160,Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0812-6
161,Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0805-5
162,Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0810-8
163,Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0807-3
164,Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0809-1
165,Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0806-4
166,A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0801-1
167,Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0803-z
168,Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0804-y
169,Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0802-0
170,GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0800-2
171,"Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0794-9
172,Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0799-4
173,Cognitive function in adolescence and the risk for premature diabetes and cardiovascular mortality in adulthood,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0798-5
174,Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0797-6
175,Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0795-8
176,Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0796-7
177,Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0787-8
178,Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0792-y
179,Does glucagon have a positive inotropic effect in the human heart?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0791-z
180,Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0793-x
181,"Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0789-6
182,Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0788-7
183,A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0790-0
184,Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0786-9
185,The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0785-x
186,Platelet activity and hypercoagulation in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0783-z
187,Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0784-y
188,Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0782-0
189,Lower extremity arterial disease in patients with diabetes: a contemporary narrative review,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0781-1
190,"Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0778-9
191,Hyperglycemia and risk of ventricular tachycardia among patients hospitalized with acute myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0779-8
192,Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical aortic valve replacement in Spain (2001–2015),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0780-2
193,Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0777-x
194,Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0776-y
195,Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0775-z
196,Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0774-0
197,Both pre-frailty and frailty increase healthcare utilization and adverse health outcomes in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0772-2
198,Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0773-1
199,Early vascular parameters in the micro- and macrocirculation in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0770-4
200,ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0771-3
201,The role of physical activity in the development of first cardiovascular disease event: a tree-structured survival analysis of the Danish ADDITION-PRO cohort,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0769-x
202,Type 2 diabetes is independently associated with all-cause mortality secondary to ventricular tachyarrhythmias,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0768-y
203,Midlife development of type 2 diabetes and hypertension in women by history of hypertensive disorders of pregnancy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0764-2
204,MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0767-z
205,Association between insulin resistance and the development of cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0762-4
206,Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0763-3
207,Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0765-1
208,Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0766-0
209,Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0759-z
210,Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0760-6
211,Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0761-5
212,Correction to: Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α’,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0757-1
213,Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0758-0
214,Overweight and obesity impair left ventricular systolic function as measured by left ventricular ejection fraction and global longitudinal strain,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0756-2
215,Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0755-3
216,Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α’,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0754-4
217,"Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0753-5
218,Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0752-6
219,"Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0750-8
220,Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0751-7
221,Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0749-1
222,Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0748-2
223,"Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0744-6
224,"β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0747-3
225,Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0746-4
226,Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0687-y
227,Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0745-5
228,Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0743-7
229,Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0741-9
230,Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0740-x
231,"Interaction between endothelial nitric oxide synthase rs1799983, cholesteryl ester-transfer protein rs708272 and angiopoietin-like protein 8 rs2278426 gene variants highly elevates the risk of type 2 diabetes mellitus and cardiovascular disease",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0742-8
232,Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0739-3
233,"Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0735-7
234,Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0738-4
235,Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0734-8
236,Associations between circulating full-length angiopoietin-like protein 8 levels and severity of coronary artery disease in Chinese non-diabetic patients: a case–control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0736-6
237,Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0737-5
238,Non-culprit plaque characteristics in acute coronary syndrome patients with raised hemoglobinA1c: an intravascular optical coherence tomography study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0729-5
239,Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0732-x
240,"Association between abdominal adiposity and subclinical measures of left-ventricular remodeling in diabetics, prediabetics and normal controls without history of cardiovascular disease as measured by magnetic resonance imaging: results from the KORA-FF4 Study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0721-0
241,Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the ‘common soil’ hypothesis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0733-9
242,Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0730-z
243,Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0731-y
244,Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0728-6
245,Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0718-8
246,Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0725-9
247,Sex-specific associations between adolescent categories of BMI with cardiovascular and non-cardiovascular mortality in midlife,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0727-7
248,"Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0722-z
249,Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0720-1
250,Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0726-8
251,Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0723-y
252,Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0719-7
253,Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0717-9
254,The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0702-3
255,No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0715-y
256,"Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0716-x
257,Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case–control analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0712-1
258,Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0707-y
259,Adverse effects of Hif1a mutation and maternal diabetes on the offspring heart,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0713-0
260,Associations of coronary artery calcified plaque density with mortality in type 2 diabetes: the Diabetes Heart Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0714-z
261,Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0706-z
262,The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0709-9
263,Exercise training and endothelial function in patients with type 2 diabetes: a meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0711-2
264,"Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0698-8
265,Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0710-3
266,SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0708-x
267,Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0705-0
268,The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0704-1
269,Prevalence of left ventricular systolic dysfunction and heart failure with reduced ejection fraction in men and women with type 2 diabetes mellitus: a systematic review and meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0690-3
270,"Diabetes, cardiovascular disease and the microcirculation",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0703-2
271,Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0700-5
272,Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0699-7
273,Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0701-4
274,Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0695-y
275,"The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0694-z
276,Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0697-9
277,Correction to: Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0696-x
278,Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0689-9
279,HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0693-0
280,"The role of obesity in carotid plaque instability: interaction with age, gender, and cardiovascular risk factors",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0685-0
281,Bone markers and cardiovascular risk in type 2 diabetes patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0691-2
282,Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0688-x
283,Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0684-1
284,Correction to: HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0686-z
285,Association between triglyceride glucose index and arterial stiffness in Korean adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0692-1
286,Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0679-y
287,"Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0682-3
288,Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0676-1
289,Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0680-5
290,Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0683-2
291,Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0681-4
292,MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0678-z
293,Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0677-0
294,The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0674-3
295,Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0675-2
296,Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0667-2
297,"Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0672-5
298,Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0670-7
299,Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0673-4
300,Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0671-6
301,Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0671-6
302,Impact of diabetes and early revascularization on the need for late and repeat procedures,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0669-0
303,Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0666-3
304,Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0659-2
305,How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0668-1
306,Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0665-4
307,Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0663-6
308,Association of depression with evolution of heart failure in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0664-5
309,Individualised treatment targets in patients with type-2 diabetes and hypertension,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0661-8
310,Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0647-y
311,p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0660-9
312,Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0657-9
313,Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0662-7
314,Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0645-0
315,Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0643-2
316,Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0652-1
317,Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0650-3
318,Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0648-x
319,"Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0646-z
320,Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0651-2
321,The effect of dapagliflozin treatment on epicardial adipose tissue volume,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0658-8
322,SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0654-z
323,Evaluation of the impact of glycemic status on the progression of coronary artery calcification in asymptomatic individuals,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0653-0
324,"Body mass index, type 2 diabetes, and left ventricular function",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0649-9
325,Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0655-y
326,"Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0656-x
327,Impaired ventricular filling limits cardiac reserve during submaximal exercise in people with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0644-1
328,Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0640-5
329,Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0641-4
330,Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0642-3
331,Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0637-0
332,Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0638-z
333,DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0639-y
334,"Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0634-3
335,Type 2 diabetes mellitus is associated with a lower fibrous cap thickness but has no impact on calcification morphology: an intracoronary optical coherence tomography study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0635-2
336,"Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0%",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0636-1
337,Correction to: Updates on cardiovascular outcome trials in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0633-4
338,Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0608-5
339,Effects of hypoglycemia on myocardial susceptibility to ischemia–reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0628-1
340,Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0627-2
341,RETRACTED ARTICLE: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0629-0
342,Impact of overweight on left ventricular function in type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0632-5
343,Transcatheter aortic valve implantation and surgical aortic valve replacement among hospitalized patients with and without type 2 diabetes mellitus in Spain (2014–2015),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0631-6
344,Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0626-3
345,"Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0625-4
346,Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0624-5
347,Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0623-6
348,Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0620-9
349,"Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0621-8
350,Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0622-7
351,Correction to: Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0614-7
352,Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0616-5
353,Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0617-4
354,Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0612-9
355,"The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0613-8
356,Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0618-3
357,Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0615-6
358,Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0611-x
359,Updates on cardiovascular outcome trials in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0610-y
360,Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0619-2
361,Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0609-4
362,"The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0607-6
363,"Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0602-y
364,Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0606-7
365,The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0603-x
366,High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0605-8
367,Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0604-9
368,"NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0601-z
369,Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0600-0
370,Erratum to: Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0597-4
371,High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0599-2
372,Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0598-3
373,The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0594-7
374,Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0595-6
375,"A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0593-8
376,Association between carotid plaque characteristics and acute cerebral infarction determined by MRI in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0592-9
377,The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: a systematic review and meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0590-y
378,Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0591-x
379,Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0589-4
380,Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0587-6
381,Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0588-5
382,New onset diabetes in adulthood is associated with a substantial risk for mortality at all ages: a population based historical cohort study with a decade-long follow-up,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0583-x
383,Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0586-7
384,Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0584-9
385,Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0582-y
386,Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0585-8
387,Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004–2014,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0580-0
388,Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0581-z
389,Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0579-6
390,Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0578-7
391,Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0577-8
392,"Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0575-x
393,"Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0576-9
394,Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0574-y
395,Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0568-9
396,Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0573-z
397,Erratum to: Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0562-2
398,The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0572-0
399,"Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0569-8
400,Joint analysis of left ventricular expression and circulating plasma levels of Omentin after myocardial ischemia,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0567-x
401,"α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0571-1
402,Reduced HDL function in children and young adults with type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0570-2
403,Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0564-0
404,Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0566-y
405,Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0563-1
406,In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0561-3
407,Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findings,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0560-4
408,"Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0557-z
409,Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0559-x
410,The regulatory role of DPP4 in atherosclerotic disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0558-y
411,"Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0554-2
412,"Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0556-0
413,The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0555-1
414,Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0553-3
415,"Platelets, diabetes and myocardial ischemia/reperfusion injury",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0550-6
416,Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0552-4
417,"The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0551-5
418,PRotective Effect on the coronary microcirculation of patients with DIabetes by Clopidogrel or Ticagrelor (PREDICT): study rationale and design. A randomized multicenter clinical trial using intracoronary multimodal physiology,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0543-5
419,"Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0549-z
420,The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0548-0
421,SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0547-1
422,Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0542-6
423,Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0546-2
424,Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0545-3
425,"Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0544-4
426,Erratum to: Inhibition of dynamin-related protein 1 protects against myocardial ischemia–reperfusion injury in diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0540-8
427,Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0541-7
428,Erratum to: Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0538-2
429,Remote ischemic preconditioning differentially attenuates post-ischemic cardiac arrhythmia in streptozotocin-induced diabetic versus nondiabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0537-3
430,Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0534-6
431,Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0539-1
432,Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008–2011),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0536-4
433,Erratum to: Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0535-5
434,Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0531-9
435,Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0533-7
436,"Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0523-9
437,Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0530-x
438,Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0532-8
439,Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet-induced obese rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0525-7
440,Human serum RNase-L level is inversely associated with metabolic syndrome and age,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0522-x
441,Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0526-6
442,Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0528-4
443,Glycemia and the cardioprotective effects of insulin pre-conditioning in the isolated rat heart,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0527-5
444,"Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0529-3
445,Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0524-8
446,Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0517-7
447,Association between obstructive sleep apnea severity and endothelial dysfunction in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0521-y
448,Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0520-z
449,Clinical outcomes and glycaemic responses to different aerobic exercise training intensities in type II diabetes: a systematic review and meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0518-6
450,Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0519-5
451,Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0508-8
452,Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0515-9
453,The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0513-y
454,Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0516-8
455,Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0512-z
456,Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0514-x
457,"Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0511-0
458,Diagnostic approaches for diabetic cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0506-x
459,"Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0503-0
460,A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0510-1
461,"Erratum to: Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0502-1
462,Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0509-7
463,Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0500-3
464,DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0507-9
465,Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0504-z
466,Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0505-y
467,Inhibition of dynamin-related protein 1 protects against myocardial ischemia–reperfusion injury in diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0501-2
468,Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0499-5
469,"Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0498-6
470,The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0497-7
471,Skin autofluorescence is associated with inappropriate left ventricular mass and diastolic dysfunction in subjects at risk for cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0495-9
472,"Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0496-8
473,"A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0493-3
474,T-cadherin deficiency increases vascular vulnerability in T2DM through impaired NO bioactivity,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0488-0
475,The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: a systematic review with meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0487-1
476,Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0484-4
477,Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0489-z
478,Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0491-5
479,Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0494-2
480,Differential effects of glucagon-like peptide-1 receptor agonists on heart rate,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0490-6
481,Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0492-4
482,Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0486-2
483,Blood pressure control in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0485-3
484,"Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0483-5
485,Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006–2013),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0482-6
486,Impact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0481-7
487,Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0476-4
488,Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0480-8
489,"Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0477-3
490,Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0478-2
491,Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0479-1
492,"Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0475-5
493,Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0473-7
494,Correlation between insulin-induced estrogen receptor methylation and atherosclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0471-9
495,Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0474-6
496,"Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0469-3
497,Effect of trelagliptin on vascular endothelial functions and serum adiponectin level in patients with type 2 diabetes: a preliminary single-arm prospective pilot study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0468-4
498,Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0467-5
499,Impact of diabetes on the predictive value of heart failure biomarkers,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0470-x
500,Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0472-8
501,Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0466-6
502,Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0465-7
503,Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0463-9
504,N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0460-z
505,"Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0459-5
506,Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT–FFR) prospective study. Rationale and design,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0464-8
507,Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0462-x
508,Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0461-y
509,A 19-SNP coronary heart disease gene score profile in subjects with type 2 diabetes: the coronary heart disease risk in type 2 diabetes (CoRDia study) study baseline characteristics,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0457-7
510,Association of serum calcium and heart failure with preserved ejection fraction in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0458-6
511,Current perspectives on cardiovascular outcome trials in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0456-8
512,Associations between explorative dietary patterns and serum lipid levels and their interactions with ApoA5 and ApoE haplotype in patients with recently diagnosed type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0455-9
513,Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0454-x
514,Acute hyperglycemia suppresses left ventricular diastolic function and inhibits autophagic flux in mice under prohypertrophic stimulation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0452-z
515,The effect of perioperative insulin treatment on cardiodepression in mild adiposity in mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0453-y
516,Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0438-x
517,Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0449-7
518,Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0450-1
519,Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0451-0
520,Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0444-z
521,Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0446-x
522,Adequate vitamin D status is associated with the reduced odds of prevalent diabetic retinopathy in African Americans and Caucasians,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0434-1
523,Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0448-8
524,Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0442-1
525,Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case–control analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0447-9
526,Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0429-y
527,Glucagon and heart in type 2 diabetes: new perspectives,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0440-3
528,Association between dietary acid load and the risk of cardiovascular disease: nationwide surveys (KNHANES 2008–2011),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0436-z
529,"Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0437-y
530,Common dysregulated pathways in obese adipose tissue and atherosclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0441-2
531,Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0413-6
532,TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0443-0
533,Associations between blood glucose level and outcomes of adult in-hospital cardiac arrest: a retrospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0445-y
534,Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0439-9
535,"Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0435-0
536,Glucose intolerance after chronic stress is related with downregulated PPAR-γ in adipose tissue,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0433-2
537,Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0430-5
538,"High levels of serum vitamin D are associated with a decreased risk of metabolic diseases in both men and women, but an increased risk for coronary artery calcification in Korean men",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0432-3
539,Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0431-4
540,Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0424-3
541,"Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0427-0
542,Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0426-1
543,Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0428-z
544,The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0420-7
545,Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0425-2
546,Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0415-4
547,Erratum to: National trends in incidence and outcomes of abdominal aortic aneurysm among elderly type 2 diabetic and non-diabetic patients in Spain (2003–2012),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0423-4
548,Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0421-6
549,The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0418-1
550,Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0417-2
551,Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0417-2
552,Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0416-3
553,The relationship between HbA1c and ultrasound plaque textures in atherosclerotic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0422-5
554,Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0419-0
555,Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0410-9
556,Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0412-7
557,Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0414-5
558,Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0401-x
559,Impact of metabolic syndrome on the progression of coronary calcium and of coronary artery disease assessed by repeated cardiac computed tomography scans,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0404-7
560,Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0411-8
561,Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0406-5
562,"Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0407-4
563,Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0408-3
564,"Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0409-2
565,"Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0405-6
566,The EMPA-REG outcome study: critical appraisal and potential clinical implications,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0403-8
567,The nine-year changes of the incidence and characteristics of metabolic syndrome in China: longitudinal comparisons of the two cross-sectional surveys in a newly formed urban community,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0402-9
568,Diastolic orthostatic hypertension and cardiovascular prognosis in type 2 diabetes: a prospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0399-0
569,"Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0397-2
570,Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0400-y
571,Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0398-1
572,Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0395-4
573,Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0393-6
574,Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0394-5
575,Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0396-3
576,Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0383-8
577,"The prevalence of diabetes, hypertension and obesity among immigrants from East Africa and the former Soviet Union: a retrospective comparative 30-year cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0392-7
578,"Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0389-2
579,"Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0391-8
580,Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0390-9
581,The source of circulating selenoprotein S and its association with type 2 diabetes mellitus and atherosclerosis: a preliminary study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0388-3
582,The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0387-4
583,Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0385-6
584,Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0380-y
585,Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R+ T cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0378-5
586,Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0386-5
587,Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0384-7
588,Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca2+ handling in smooth muscle cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0382-9
589,Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0377-6
590,Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0375-8
591,Cohort profile: the German Diabetes Study (GDS),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0374-9
592,The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0370-0
593,Association between socioeconomic status and metabolic control and diabetes complications: a cross-sectional nationwide study in Chinese adults with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0376-7
594,Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0381-x
595,A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0365-x
596,Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0379-4
597,Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0371-z
598,Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0372-y
599,Flow cytometric analysis of platelets type 2 diabetes mellitus reveals ‘angry’ platelets,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0373-x
600,"Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0369-6
601,Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0362-0
602,Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0367-8
603,Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0363-z
604,Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0368-7
605,Protective effect of resveratrol and quercetin on in vitro-induced diabetic mouse corpus cavernosum,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0366-9
606,Association of glucose homeostasis measures with heart rate variability among Hispanic/Latino adults without diabetes: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0364-y
607,Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0361-1
608,The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0360-2
609,Interleukin-1β mediates high glucose induced phenotypic transition in human aortic endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0358-9
610,Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0350-4
611,"Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0359-8
612,Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0347-z
613,Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0355-z
614,Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0356-y
615,"Insulin resistance, endothelial function, angiogenic factors and clinical outcome in non-diabetic patients with chest pain without myocardial perfusion defects",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0353-1
616,Erratum to: Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0354-0
617,Diabetes is an independent predictor of right ventricular dysfunction post ST-elevation myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0352-2
618,Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0357-x
619,Upregulation of inducible NO synthase by exogenous adenosine in vascular smooth muscle cells activated by inflammatory stimuli in experimental diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0349-x
620,Early changes in cardiovascular structure and function in adolescents with type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0351-3
621,Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0343-3
622,LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0341-5
623,Use of imaging and clinical data to screen for cardiovascular disease in asymptomatic diabetics,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0334-4
624,Metformin improves the angiogenic potential of human CD34+ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0344-2
625,Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer 18F-fluoromethylcholine,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0340-6
626,Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0346-0
627,Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0348-y
628,Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0345-1
629,Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0333-5
630,Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0330-8
631,Evaluation of pleiotropic effects among common genetic loci identified for cardio-metabolic traits in a Korean population,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0337-1
632,Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0325-x
633,High glucose-induced hyperosmolarity contributes to COX-2 expression and angiogenesis: implications for diabetic retinopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0342-4
634,Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0339-z
635,Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0328-2
636,Early cardiovascular events in women with a history of gestational diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0338-0
637,Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0318-9
638,Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0336-2
639,Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0329-1
640,Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0332-6
641,Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0335-3
642,The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0319-8
643,Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-016-0331-7
644,Effects of analogue insulin in multiple daily injection therapy of type 2 diabetes on postprandial glucose control and cardiac function compared to human insulin: a randomized controlled long-term study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0320-2
645,"Reduction of CTRP9, a novel anti-platelet adipokine, contributes to abnormal platelet activity in diabetic animals",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0321-1
646,Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0322-0
647,CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0327-8
648,Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0326-9
649,Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0323-z
650,Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0324-y
651,"Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0314-0
652,Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0316-y
653,Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0315-z
654,Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0313-1
655,Early impairment of coronary microvascular perfusion capacity in rats on a high fat diet,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0312-2
656,Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0308-y
657,"Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0310-4
658,Association between brachial-ankle pulse wave velocity and progression of coronary artery calcium: a prospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0311-3
659,Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0307-z
660,The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0309-x
661,Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0306-0
662,SIRT1 protects against myocardial ischemia–reperfusion injury via activating eNOS in diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0299-8
663,"Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0297-x
664,Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0305-1
665,Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0303-3
666,Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0301-5
667,Erratum to: Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0295-z
668,Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0304-2
669,High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0302-4
670,Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0300-6
671,Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0298-9
672,Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0296-y
673,Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0293-1
674,Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0291-3
675,Impact of long-term steroid therapy on epicardial and pericardial fat deposition: a cardiac MRI study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0289-x
676,Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0294-0
677,"Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0290-4
678,Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0286-0
679,Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0292-2
680,Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0288-y
681,HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0285-1
682,Altered myocardial response in patients with diabetic retinopathy: an exercise echocardiography study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0281-5
683,Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imaging,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0284-2
684,Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0287-z
685,Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0283-3
686,Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0282-4
687,Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0266-4
688,Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0280-6
689,Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0279-z
690,"PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0268-2
691,Short-term high glucose exposure impairs insulin signaling in endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0278-0
692,Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0276-2
693,Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0277-1
694,Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0275-3
695,Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0274-4
696,The pleiotropic effects of metformin: time for prospective studies,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0273-5
697,Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0272-6
698,Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0270-8
699,Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0269-1
700,Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0267-3
701,Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muscle cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0271-7
702,Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0264-6
703,Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0259-3
704,Sensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0265-5
705,Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0260-x
706,Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0262-8
707,Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0263-7
708,MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0252-x
709,Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0261-9
710,A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0254-8
711,Partial inhibition of the ubiquitin–proteasome system ameliorates cardiac dysfunction following ischemia–reperfusion in the presence of high glucose,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0258-4
712,"The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0257-5
713,Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0256-6
714,Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0251-y
715,Rutin administration attenuates myocardial dysfunction in diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0255-7
716,Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0250-z
717,Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0253-9
718,Diet-induced pre-diabetes slows cardiac conductance and promotes arrhythmogenesis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0246-8
719,Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography® study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0249-5
720,"The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0248-6
721,Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0247-7
722,Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0242-z
723,Relationship between serum osteocalcin level and carotid intima-media thickness in a metabolically healthy Chinese population,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0245-9
724,"Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0243-y
725,"High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0244-x
726,Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0240-1
727,Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0236-x
728,Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0241-0
729,Chronic NF-κB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0239-7
730,Protective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0237-9
731,Association of insulin resistance and coronary artery remodeling: an intravascular ultrasound study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0238-8
732,Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0230-3
733,Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0229-9
734,"The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0235-y
735,The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0233-0
736,Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0234-z
737,Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0232-1
738,"Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0231-2
739,Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0228-x
740,Erratum: PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0205-4
741,Increased plasma BMP-2 levels are associated with atherosclerosis burden and coronary calcification in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0214-3
742,Predictive value of dynamic renal resistive index (drin) for renal outcome in type 2 diabetes and essential hypertension: a prospective study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0227-y
743,Serum leptin levels are independently related to the incidence of ischemic heart disease in a prospective study of patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0208-1
744,Longitudinal association of C-reactive protein and Haemoglobin A1c over 13 years: the European Prospective Investigation into Cancer - Norfolk study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0224-1
745,"Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0226-z
746,Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0225-0
747,Normal-weight obesity is associated with increased risk of subclinical atherosclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0220-5
748,Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0215-2
749,Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0223-2
750,DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0218-z
751,Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0222-3
752,Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0219-y
753,"Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0221-4
754,Treadmill running improves hindlimb arteriolar endothelial function in type 1 diabetic mice as visualized by X-ray microangiography,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0217-0
755,The amount of C1q–adiponectin complex is higher in the serum and the complex localizes to perivascular areas of fat tissues and the intimal–medial layer of blood vessels of coronary artery disease patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0209-0
756,Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0212-5
757,National trends in incidence and outcomes of abdominal aortic aneurysm among elderly type 2 diabetic and non-diabetic patients in Spain (2003–2012),http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0216-1
758,Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0213-4
759,Epicardial fat thickness is associated to type 2 diabetes mellitus in Korean men: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0210-7
760,Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0211-6
761,Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0207-2
762,Cross-sectional analysis of serum calcium levels for associations with left ventricular hypertrophy in normocalcemia individuals with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0200-9
763,Polymorphisms of the Peroxisome Proliferator-Activated Receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0197-0
764,"Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0206-3
765,The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0203-6
766,Isocaloric substitution of carbohydrates with protein: the association with weight change and mortality among patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0202-7
767,"Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0204-5
768,Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0201-8
769,Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for carotid atherosclerosis in hospital-based patients with type 2 diabetes: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0199-y
770,Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0198-z
771,Acknowledgement of manuscript reviewers 2014,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0186-3
772,Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0196-1
773,Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0190-7
774,"Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0195-2
775,Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0192-5
776,Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0194-3
777,"Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0191-6
778,"Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0193-4
779,Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0185-4
780,Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0188-1
781,Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0189-0
782,Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0187-2
783,Activation of TRPV1 channel by dietary capsaicin improves visceral fat remodeling through connexin43-mediated Ca2+ Influx,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0183-6
784,Glucose and triglyceride excursions following a standardized meal in individuals with diabetes: ELSA-Brasil study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0181-8
785,Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0184-5
786,Inhibition of protein kinase C enhances angiogenesis induced by platelet-derived growth factor C in hyperglycemic endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0180-9
787,"Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0177-4
788,Targeting metabolic disturbance in the diabetic heart,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0173-8
789,"Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0166-z
790,The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0182-7
791,"Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0179-2
792,A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0172-9
793,"Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0171-2
794,"Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0169-9
795,The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0178-3
796,Erratum: Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0164-1
797,Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0174-7
798,"Cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, LOD-DIABETES study: a case series report",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0167-y
799,Involvement of peroxisome proliferator-activated receptors in cardiac and vascular remodeling in a novel minipig model of insulin resistance and atherosclerosis induced by consumption of a high-fat/cholesterol diet,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0165-0
800,"Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0170-3
801,"Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0163-2
802,"Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0168-x
803,Higher blood aldosterone level in metabolic syndrome is independently related to adiposity and fasting plasma glucose,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0175-6
804,Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-015-0176-5
805,Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0162-3
806,The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0158-z
807,Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0160-5
808,Increased haemodynamic adrenergic load with isoflurane anaesthesia in type 2 diabetic and obese rats in vivo,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0161-4
809,Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0159-y
810,Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0156-1
811,DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0157-0
812,Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0149-0
813,Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0155-2
814,Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0154-3
815,Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0153-4
816,The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0140-9
817,Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0152-5
818,Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0151-6
819,PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0150-7
820,"Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0147-2
821,Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0145-4
822,Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0139-2
823,"Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0148-1
824,Aortic reservoir characteristics and brain structure in people with type 2 diabetes mellitus; a cross sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0143-6
825,Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0142-7
826,Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0141-8
827,"Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0146-3
828,Obesity attenuates gender differences in cardiovascular mortality,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0144-5
829,"Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0137-4
830,Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0135-6
831,Diabetic hyperglycemia attenuates sympathetic dysfunction and oxidative stress after myocardial infarction in rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0131-x
832,Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0138-3
833,Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0136-5
834,Endothelial Na+/H+ exchanger NHE1 participates in redox-sensitive leukocyte recruitment triggered by methylglyoxal,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0134-7
835,Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0129-4
836,A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0133-8
837,Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0130-y
838,Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0132-9
839,Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0128-5
840,"Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0127-6
841,Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0126-7
842,Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0125-8
843,Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0124-9
844,Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0121-z
845,Nestin downregulation in rat vascular smooth muscle cells represents an early marker of vascular disease in experimental type I diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0119-6
846,Cardiac contractile function and mitochondrial respiration in diabetes-related mouse models,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0118-7
847,A score to quantify coronary plaque vulnerability in high-risk patients with type 2 diabetes: an optical coherence tomography study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0117-8
848,"Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0112-0
849,EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0114-y
850,Sinoatrial node dysfunction induces cardiac arrhythmias in diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0122-y
851,Right ventricle free wall mechanics in metabolic syndrome without type-2 diabetes: effects of a 3-month lifestyle intervention program,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0116-9
852,High or low calcium intake increases cardiovascular disease risks in older patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0120-0
853,GLP-1 (7–36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0115-x
854,Antagonistic effect of TNF-alpha and insulin on uncoupling protein 2 (UCP-2) expression and vascular damage,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0108-9
855,Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0106-y
856,DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0110-2
857,p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-Uncoupling in Obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0113-z
858,High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0109-8
859,"Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study",http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0111-1
860,Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-112
861,Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-105
862,Neck circumference and early stage atherosclerosis: the cardiometabolic risk in Chinese (CRC) study,http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-014-0107-x
863,Group-based activities with on-site childcare and online support improve glucose tolerance in women within 5 years of gestational diabetes pregnancy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-104
864,"Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-103
865,"Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-102
866,Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-101
867,Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-100
868,"Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-99
869,Caffeic acid phenethyl amide ameliorates ischemia/reperfusion injury and cardiac dysfunction in streptozotocin-induced diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-98
870,Dopamine D4 receptors inhibit proliferation and migration of vascular smooth muscle cells induced by insulin via down-regulation of insulin receptor expression,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-97
871,A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus- a randomized controlled trial START-J study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-96
872,Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-95
873,"Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-94
874,The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-92
875,Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-91
876,PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-90
877,High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-89
878,Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-88
879,"Influence of a family history of type 2 diabetes, demographic and clinical data on carotid intima-media thickness in patients with type 1 diabetes: a cross-sectional study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-87
880,Insulin resistance and subclinical abnormalities of global and regional left ventricular function in patients with aortic valve sclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-86
881,Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-85
882,Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-84
883,Low sensitivity of the metabolic syndrome to identify adolescents with impaired glucose tolerance: an analysis of NHANES 1999–2010,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-83
884,The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-82
885,On the potential of acarbose to reduce cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-81
886,"Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-80
887,Streptozotocin-induced diabetes prolongs twitch duration without affecting the energetics of isolated ventricular trabeculae,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-79
888,Advanced glycation endproducts trigger autophagy in cadiomyocyte Via RAGE/PI3K/AKT/mTOR pathway,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-78
889,Analysis of common and coding variants with cardiovascular disease in the diabetes heart study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-77
890,Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-76
891,Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-75
892,Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-74
893,Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-73
894,Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-72
895,Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-71
896,Subclinical vascular inflammation in subjects with normal weight obesity and its association with body Fat: an 18 F-FDG-PET/CT study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-70
897,"Exenatide induces aortic vasodilation increasing hydrogen sulphide, carbon monoxide and nitric oxide production",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-69
898,Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-68
899,Cardiovascular guidelines: separate career may help attenuate controversy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-66
900,"Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-65
901,Contribution of subcutaneous abdominal fat on ultrasonography to carotid atherosclerosis in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-67
902,"Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-65
903,Gender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDL,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-64
904,Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-63
905,Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: a pilot study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-62
906,Differential association of visceral adipose tissue with coronary plaque characteristics in patients with and without diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-61
907,Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-60
908,Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-59
909,Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-58
910,Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-57
911,Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-56
912,AGEs breaking and antioxidant treatment improves endothelium-dependent dilation without effect on flow-mediated remodeling of resistance arteries in old Zucker diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-55
913,Body adiposity dictates different mechanisms of increased coronary reactivity related to improved in vivo cardiac function,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-54
914,High glucose induces human endothelial dysfunction through an Axl-dependent mechanism,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-53
915,The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-52
916,Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-51
917,Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-50
918,Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-49
919,Vitamin D and 1-hour post-load plasma glucose in hypertensive patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-48
920,Differential transendothelial transport of adiponectin complexes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-47
921,N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-46
922,Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-45
923,Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-44
924,"Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-43
925,Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-42
926,Vaspin inhibits cytokine-induced nuclear factor-kappa B activation and adhesion molecule expression via AMP-activated protein kinase activation in vascular endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-41
927,Erratum to: CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-17
928,Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-40
929,Evaluation of carotid artery elasticity changes in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-39
930,Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-38
931,Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-37
932,Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-36
933,Kir6.2-containing ATP-sensitive K+ channel is required for cardioprotection of resveratrol in mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-35
934,Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-34
935,Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-33
936,The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-32
937,Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-31
938,"Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-30
939,Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-29
940,Annual acknowledgement of manuscript reviewers,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-18
941,The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-28
942,"CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-27
943,Residual macrovascular risk in 2013: what have we learned?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-26
944,Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-25
945,Long term liver specific glucokinase gene defect induced diabetic cardiomyopathy by up regulating NADPH oxidase and down regulating insulin receptor and p-AMPK,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-24
946,An accelerated mouse model for atherosclerosis and adipose tissue inflammation,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-23
947,Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-22
948,Do incretins improve endothelial function?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-21
949,Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-20
950,Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-15
951,Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-19
952,A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-16
953,Implications of C1q/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-14
954,Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus: results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-13
955,Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-12
956,The co-occurrence of myocardial dysfunction and peripheral insensate neuropathy in a streptozotocin-induced rat model of diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-11
957,Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-10
958,High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-9
959,"Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-8
960,Step Monitoring to improve ARTERial health (SMARTER) through step count prescription in type 2 diabetes and hypertension: trial design and methods,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-7
961,Exercise increases serum endostatin levels in female and male patients with diabetes and controls,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-6
962,Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-5
963,The afterload-dependent peak efficiency of the isolated working rat heart is unaffected by streptozotocin-induced diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-4
964,National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001–2011),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-3
965,Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-2
966,Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-13-1
967,Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-177
968,Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-176
969,Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db/db mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-175
970,Do patients with type 1 and type 2 diabetes really have an impaired endothelial function? A population-based propensity score matching analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-174
971,Metabolic disturbances and worsening of atherosclerotic lesions in ApoE-/- mice after cola beverages drinking,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-57
972,Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-173
973,"Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-172
974,High admission glucose levels increase Fas apoptosis and mortality in patients with acute ST-elevation myocardial infarction: a prospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-171
975,Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-170
976,"Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-169
977,Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-168
978,Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-167
979,High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-166
980,Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-165
981,Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-164
982,"Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-163
983,"Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-162
984,Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-161
985,Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-160
986,Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-159
987,Protein kinase RNA- like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)- mediated endoplasmic reticulum stress- induced apoptosis in diabetic cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-158
988,Long-term prognostic impact of cystatin c on acute coronary syndrome octogenarians with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-157
989,Erratum to: The metabolic syndrome and progression of carotid atherosclerosis over 13 years: the Tromsø study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-144
990,Type 1 diabetes and cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-156
991,Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-155
992,Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-154
993,The relationship between early atherosclerosis and endothelial dysfunction in type 1 diabetic patients as evidenced by measurement of carotid intima-media thickness and soluble CD146 levels: a cross sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-153
994,Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-152
995,Arg972 Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidence,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-151
996,Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-150
997,Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-149
998,Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-148
999,Interferon regulatory factor-1 together with reactive oxygen species promotes the acceleration of cell cycle progression by up-regulating the cyclin E and CDK2 genes during high glucose-induced proliferation of vascular smooth muscle cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-147
1000,Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-146
1001,Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-145
1002,The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-143
1003,Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-142
1004,The role of profilin-1 in endothelial cell injury induced by advanced glycation end products (AGEs),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-141
1005,Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-140
1006,Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-139
1007,Lipoprotein(a) is not related to markers of insulin resistance in pregnancy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-138
1008,Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-137
1009,Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-136
1010,Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-135
1011,Methylglyoxal modulates endothelial nitric oxide synthase-associated functions in EA.hy926 endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-134
1012,Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-133
1013,Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-132
1014,"Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-131
1015,The cardiovascular safety of incretin-based therapies: a review of the evidence,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-130
1016,"Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-129
1017,Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-128
1018,Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-127
1019,Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-126
1020,Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-125
1021,Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-124
1022,Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-123
1023,Erratum to: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-120
1024,24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes – a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-122
1025,Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-121
1026,Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-119
1027,Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-118
1028,Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-117
1029,Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-116
1030,Impaired skin microcirculation in paediatric patients with type 1 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-115
1031,The neurogenic response of cardiac resident nestin(+) cells was associated with GAP43 upregulation and abrogated in a setting of type I diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-114
1032,Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-113
1033,"Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-112
1034,"Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-111
1035,Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-110
1036,Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-109
1037,Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-108
1038,Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-107
1039,"Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-106
1040,"Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-105
1041,Inverse associations between light-to-moderate alcohol intake and lipid-related indices in patients with diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-104
1042,"Effects of FTO RS9939906 and MC4R RS17782313 on obesity, type 2 diabetes mellitus and blood pressure in patients with hypertension",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-103
1043,Plaque vulnerability of coronary artery lesions is related to left ventricular dilatation as determined by optical coherence tomography and cardiac magnetic resonance imaging in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-102
1044,Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A/HDAC1/2 complex in the heart,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-101
1045,"Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-100
1046,Caffeic acid phenethyl amide improves glucose homeostasis and attenuates the progression of vascular dysfunction in Streptozotocin-induced diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-99
1047,Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-98
1048,Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-97
1049,Stiffness memory of EA.hy926 endothelial cells in response to chronic hyperglycemia,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-96
1050,Impact of HDL genetic risk scores on coronary artery calcified plaque and mortality in individuals with type 2 diabetes from the Diabetes Heart Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-95
1051,Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-94
1052,Association of arterial stiffness with single nucleotide polymorphism rs1333049 and metabolic risk factors,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-93
1053,Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-92
1054,Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-91
1055,Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-90
1056,"Metabolic, hemodynamic and structural adjustments to low intensity exercise training in a metabolic syndrome model",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-89
1057,Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-88
1058,"Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-87
1059,"Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-86
1060,Remodelling of the intracardiac ganglia in diabetic Goto-Kakizaki rats: an anatomical study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-85
1061,"New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-84
1062,"Diabetes severity and the role of leisure time physical exercise on cardiovascular mortality: the Nord-Trøndelag Health study (HUNT), Norway",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-83
1063,Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-82
1064,Management of hyperglycemia in type 2 diabetes: evidence and uncertainty,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-81
1065,Statin diabetogenicity: guidance for clinicians,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-S1-S3
1066,Pitavastatin in cardiometabolic disease: therapeutic profile,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-S1-S2
1067,Statins in cardiometabolic disease: what makes pitavastatin different?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-S1-S1
1068,High glucose induces upregulation of scavenger receptors and promotes maturation of dendritic cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-80
1069,HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-79
1070,Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-78
1071,Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-77
1072,Neck circumference as an independent predictive contributor to cardio-metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-76
1073,Role of Kir6.2 subunits of ATP-sensitive potassium channels in endotoxemia-induced cardiac dysfunction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-75
1074,Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-74
1075,Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-73
1076,Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-72
1077,Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-71
1078,The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-70
1079,TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-69
1080,Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-68
1081,Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-67
1082,Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-66
1083,Extensive impact of saturated fatty acids on metabolic and cardiovascular profile in rats with diet-induced obesity: a canonical analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-65
1084,Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-64
1085,The adaptability of red blood cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-63
1086,The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-62
1087,Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-61
1088,Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-60
1089,Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus – results from an exploratory study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-59
1090,The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-58
1091,Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-56
1092,Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes - a prospective observational cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-55
1093,Zinc protects against diabetes-induced pathogenic changes in the aorta: roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-54
1094,Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-53
1095,Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-52
1096,Role of ROCK upregulation in endothelial and smooth muscle vascular functions in diabetic rat aorta,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-51
1097,Annual acknowledgement of manuscript reviewers,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-43
1098,Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-50
1099,Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-49
1100,Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-48
1101,Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registry,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-47
1102,"Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-46
1103,Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-45
1104,Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-44
1105,"Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-42
1106,Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-41
1107,Impaired cardioprotective function of transplantation of mesenchymal stem cells from patients with diabetes mellitus to rats with experimentally induced myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-40
1108,Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-39
1109,Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-38
1110,Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-37
1111,Angiotensin-converting enzyme inhibition and food restriction restore delayed preconditioning in diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-36
1112,Effects of sitagliptin beyond glycemic control: focus on quality of life,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-35
1113,Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectoris,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-34
1114,Prognostic value of early in-hospital glycemic excursion in elderly patients with acute myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-33
1115,Intense exercise training is not effective to restore the endothelial NO-dependent relaxation in STZ-diabetic rat aorta,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-32
1116,Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the diabetes heart study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-31
1117,AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARγ,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-30
1118,Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-29
1119,Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-28
1120,High-density lipoprotein of patients with Type 2 Diabetes Mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-27
1121,"Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988–1991 to 2005–2008",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-26
1122,Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-25
1123,Blood glucose may be an alternative to cholesterol in CVD risk prediction charts,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-24
1124,Cardiovascular risk escalation with caloric excess: a prospective demonstration of the mechanics in healthy adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-23
1125,Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-22
1126,20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-21
1127,Macrovascular complication phenotypes in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-20
1128,Myocardial impulse propagation is impaired in right ventricular tissue of Zucker Diabetic Fatty (ZDF) rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-19
1129,Prevalence and clinical characteristics of carotid atherosclerosis in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-18
1130,"Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-17
1131,Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-16
1132,Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-15
1133,Correlation between mean platelet volume and fasting plasma glucose levels in prediabetic and normoglycemic individuals,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-14
1134,Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-13
1135,Coronary aspirate TNFα reflects saphenous vein bypass graft restenosis risk in diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-12
1136,Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-11
1137,Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-10
1138,"Blood lead is significantly associated with metabolic syndrome in Korean adults: an analysis based on the Korea National Health and Nutrition Examination Survey (KNHANES), 2008",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-9
1139,Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-8
1140,Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-7
1141,Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-6
1142,Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-5
1143,Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: Paradoxical contribution of plasma glucose level and glycohemoglobin,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-4
1144,Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-3
1145,Overweight condition and waist circumference and a candidate gene within the 12q24 locus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-2
1146,Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-12-1
1147,Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-156
1148,The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-155
1149,Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-154
1150,Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-153
1151,Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-152
1152,"Adiponectin, diabetes and ischemic heart failure: a challenging relationship",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-151
1153,Detecting DNA synthesis of neointimal formation after catheter balloon injury in GK and in Wistar rats: using 5-ethynyl-2'-deoxyuridine,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-150
1154,Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-149
1155,Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice – study rationale and protocol of DIALOGUE,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-148
1156,Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-147
1157,Principal component analysis reveals gender-specific predictors of cardiometabolic risk in 6th graders,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-146
1158,Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-145
1159,Overexpression of steroidogenic acute regulatory protein in rat aortic endothelial cells attenuates palmitic acid-induced inflammation and reduction in nitric oxide bioavailability,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-144
1160,Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-143
1161,Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-142
1162,"Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-141
1163,Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-140
1164,Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-139
1165,Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-138
1166,"Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-137
1167,Association between body size and blood pressure in children from different ethnic origins,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-136
1168,Zinc-induced cardiomyocyte relaxation in a rat model of hyperglycemia is independent of myosin isoform,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-135
1169,"Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-134
1170,"Single nucleotide polymorphisms (SNPs) involved in insulin resistance, weight regulation, lipid metabolism and inflammation in relation to metabolic syndrome: an epidemiological study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-133
1171,Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-132
1172,Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: The Taichung Diabetes Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-131
1173,Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-130
1174,Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-129
1175,A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-128
1176,Determinants of vascular function in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-127
1177,"Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-126
1178,Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-125
1179,"Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-124
1180,Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-123
1181,Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-122
1182,Both cardiovascular and non-cardiovascular comorbidity are related to health status in well-controlled type 2 diabetes patients: a cross-sectional analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-121
1183,Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-120
1184,Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-119
1185,Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-118
1186,Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-117
1187,"Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-116
1188,The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-115
1189,Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-114
1190,High glucose mediates endothelial-to-chondrocyte transition in human aortic endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-113
1191,Higher normal ranges of urine albumin-to-creatinine ratio are independently associated with carotid intima-media thickness,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-112
1192,Alpha-lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-111
1193,Increased blood glycohemoglobin A1c levels lead to overestimation of arterial oxygen saturation by pulse oximetry in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-110
1194,The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-109
1195,Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-108
1196,"Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-107
1197,Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in Japanese subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-106
1198,Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-105
1199,Ambulatory ECG-based T-wave alternans and heart rate turbulence can predict cardiac mortality in patients with myocardial infarction with or without diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-104
1200,Adipocytokine levels mark endothelial function in normotensive individuals,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-103
1201,Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-102
1202,Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 Diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-101
1203,GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-100
1204,Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-99
1205,The effects of postprandial glucose and insulin levels on postprandial endothelial function in subjects with normal glucose tolerance,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-98
1206,Insulin resistance and exercise tolerance in heart failure patients: linkage to coronary flow reserve and peripheral vascular function,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-97
1207,Sex-specific outcomes of diabetic patients with acute myocardial infarction who have undergone percutaneous coronary intervention: a register linkage study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-96
1208,"GC-MS analysis and screening of antidiabetic, antioxidant and hypolipidemic potential of Cinnamomum tamala oil in streptozotocin induced diabetes mellitus in rats",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-95
1209,Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-94
1210,2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-93
1211,Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-92
1212,Structured self-management education maintained over two years in insufficiently controlled type 2 diabetes patients: the ERMIES randomised trial in Reunion Island,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-91
1213,"The effects of low-dose Nepsilon-(carboxymethyl)lysine (CML) and Nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-90
1214,Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-89
1215,Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-88
1216,High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-87
1217,Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-86
1218,Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-85
1219,Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-84
1220,Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-83
1221,Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-82
1222,Gender difference in carotid intima-media thickness in type 2 diabetic patients: a 4-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-51
1223,Mammalian target of rapamycin signaling in diabetic cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-45
1224,"High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: Results of a cross-sectional epidemiological survey in Gran Canaria, Spain",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-81
1225,Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-80
1226,Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-79
1227,The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-78
1228,The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-77
1229,Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-76
1230,Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-75
1231,"High fat diet-induced glucose intolerance impairs myocardial function, but not myocardial perfusion during hyperaemia: a pilot study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-74
1232,Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-73
1233,Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-72
1234,Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-71
1235,Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-70
1236,Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-69
1237,"Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-68
1238,Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-67
1239,Effects of olmesartan on arterial stiffness in rats with chronic renal failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-66
1240,ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-65
1241,Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-64
1242,"GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-63
1243,The association of insulin resistance and carotid atherosclerosis with thigh and calf circumference in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-62
1244,Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-61
1245,"Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-60
1246,"Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome – a case control study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-59
1247,Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-58
1248,Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-57
1249,Let’s prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-56
1250,Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-55
1251,Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-54
1252,Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-53
1253,In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-47
1254,Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-52
1255,Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-50
1256,Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-49
1257,Expression of fourteen novel obesity-related genes in zucker diabetic fatty rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-48
1258,"Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-46
1259,Vascular memory: can we broaden the concept of the metabolic memory?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-44
1260,Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-43
1261,The CTGF gene −945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-42
1262,Uncoupling protein 2 gene polymorphisms are associated with obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-41
1263,The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-40
1264,Using the spring constant method to analyze arterial elasticity in type 2 diabeticpatients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-39
1265,Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-38
1266,Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-37
1267,Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-36
1268,Baseline comparison of three health utility measures and the feeling thermometer among participants in the action to control cardiovascular risk in diabetes trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-35
1269,Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-34
1270,The role of Na+/H+ exchanger in Ca2+ overload and ischemic myocardial damage in hearts from type 2 diabetic db/db mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-33
1271,What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-32
1272,Does insulin resistance co-exist with glucocorticoid resistance in the metabolic syndrome? Studies comparing skin sensitivity to glucocorticoids in individuals with and without acanthosis nigricans,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-31
1273,Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of Indigenous cohorts with diabetes in Australia and Canada,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-30
1274,Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-29
1275,High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-28
1276,Effects of some anti-diabetic and cardioprotective agents on proliferation and apoptosis of human coronary artery endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-27
1277,Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-26
1278,High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-25
1279,Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-24
1280,Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-23
1281,Hyperinsulinemia correlates with low levels of plasma B-type natriuretic peptide in Japanese men irrespective of fat distribution,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-22
1282,Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-21
1283,"Prognostic significance of the Complex ""Visceral Adiposity Index"" vs. simple anthropometric measures: Tehran lipid and glucose study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-20
1284,"NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-19
1285,A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-18
1286,Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-17
1287,Cut off values for abdominal obesity as a criterion of metabolic syndrome in an ethnic Kyrgyz population (Central Asian region),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-16
1288,Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-15
1289,Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-14
1290,Glycated hemoglobin and associated risk factors in older adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-13
1291,The possible role of ribosomal protein S6 kinase 4 in the senescence of endothelial progenitor cells in diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-12
1292,"Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-11
1293,Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-10
1294,Acute and chronic animal models for the evaluation of anti-diabetic agents,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-9
1295,Increase of ATP-sensitive potassium (KATP) channels in the heart of type-1 diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-8
1296,RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-7
1297,Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-6
1298,Platelet hyperaggregability in high-fat fed rats: A role for intraplatelet reactive-oxygen species production,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-5
1299,Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-4
1300,"Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-3
1301,Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-2
1302,Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-11-1
1303,"The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmö Preventive Project",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-118
1304,Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-117
1305,"A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum Calcium, -magnesium and -phosphate in Type 2 diabetes and non-diabetes metabolism",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-116
1306,A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markers,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-115
1307,CYP2J3 Gene Delivery Reduces Insulin Resistance via Upregulation of eNOS in Fructose-treated Rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-114
1308,Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-113
1309,"PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-112
1310,"Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-111
1311,Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-110
1312,"Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-109
1313,Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-108
1314,Relation between the frequency of CD34+ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-107
1315,Cardiometabolic risk variables in overweight and obese children: a worldwide comparison,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-106
1316,Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-105
1317,Dysglycemia induces abnormal circadian blood pressure variability,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-104
1318,Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-103
1319,Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-102
1320,"Toll/Interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-101
1321,Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-100
1322,Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-99
1323,Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-98
1324,"Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-97
1325,Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-96
1326,Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-95
1327,Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-94
1328,Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-93
1329,Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima Fatty rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-92
1330,Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-91
1331,Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-90
1332,An association between TRP64ARG polymorphism of the B3 adrenoreceptor gene and some metabolic disturbances,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-89
1333,Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated Type 1 Diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-88
1334,Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-87
1335,"Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-86
1336,Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-85
1337,Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: A cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-84
1338,Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-83
1339,"Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-82
1340,Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-81
1341,Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-80
1342,"Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on Glucose tolerance and ENdothelial function - a crossover Trial (AGENT)",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-79
1343,"Effect of cinnamon on gastric emptying, arterial stiffness, postprandial lipemia, glycemia, and appetite responses to high-fat breakfast",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-78
1344,Proteasome Modulator 9 SNPs are linked to hypertension in type 2 diabetes families,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-77
1345,"Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-76
1346,Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-75
1347,Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-74
1348,High glucose-induced apoptosis in human coronary artery endothelial cells involves up-regulation of death receptors,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-73
1349,Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-72
1350,"NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-71
1351,Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-70
1352,Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-69
1353,Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-68
1354,"Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-67
1355,Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients - an analysis of the DiaRegis registry,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-66
1356,"Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of Pioglitazone, Metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-65
1357,"Dietary saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early atherosclerosis and ectopic fat deposition in diabetic pigs",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-64
1358,Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-63
1359,Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-62
1360,"Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-61
1361,Low mannose-binding lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic south asians. a prospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-60
1362,Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-59
1363,Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-58
1364,Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-57
1365,A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-56
1366,Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-55
1367,YKL-40 levels are independently associated with albuminuria in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-54
1368,The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-53
1369,Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-52
1370,Association between fasting plasma glucose and high-sensitivity C-reactive protein: gender differences in a Japanese community-dwelling population,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-51
1371,Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-50
1372,Erratum to: Renal denervation in an animal model of diabetes and hypertension: Impact on the autonomic nervous system and nephropathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-49
1373,Protein Kinase C inhibition ameliorates functional endothelial insulin resistance and Vascular Smooth Muscle Cell hypersensitivity to insulin in diabetic hypertensive rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-48
1374,"Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-47
1375,Serum Non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-46
1376,Adverse effect profile of trichlormethiazide: a retrospective observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-45
1377,Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-44
1378,Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-43
1379,The interleukin-6 and noradrenaline mediated inflammation-stress feedback mechanism is dysregulated in metabolic syndrome: Effect of exercise,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-42
1380,Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-41
1381,Deficiency of mast cells in coronary artery endarterectomy of male patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-40
1382,Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-39
1383,Hypercholesterolemia and a candidate gene within the 12q24 locus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-38
1384,Heart-Type Fatty Acid Binding Protein (H-FABP): Relationship with arterial ıntima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-37
1385,Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-36
1386,Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-35
1387,Low serum amylase in association with metabolic syndrome and diabetes: A community-based study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-34
1388,Renal denervation in an animal model of diabetes and hypertension: Impact on the autonomic nervous system and nephropathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-33
1389,Proteasome modulator 9 and macrovascular pathology of T2D,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-32
1390,"Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-31
1391,Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-30
1392,Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-29
1393,N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-28
1394,A common polymorphism rs3781637 in MTNR1B is associated with type 2 diabetes and lipids levels in Han Chinese individuals,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-27
1395,Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-26
1396,Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-25
1397,Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-24
1398,Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-23
1399,Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-22
1400,Value of oral glucose tolerance test in the acute phase of myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-21
1401,Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-20
1402,Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-19
1403,Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-18
1404,Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-17
1405,The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-16
1406,Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-15
1407,Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-14
1408,Pharmacological and non-pharmacological interventions to influence adipose tissue function,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-13
1409,Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-12
1410,"""The metabolic syndrome... is dead"": These reports are an exaggeration",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-11
1411,Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-10
1412,Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-9
1413,"Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-8
1414,"Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-7
1415,Glucagon-like peptide-1 enhances cardiac L-type Ca2+ currents via activation of the cAMP-dependent protein kinase A pathway,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-6
1416,Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-5
1417,Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-4
1418,Relationship between intima-media thickness of the common carotid artery and arterial stiffness in subjects with and without type 2 diabetes: a case-series report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-3
1419,Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-2
1420,Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-1
1421,Differential expression of protein kinase C isoforms in coronary arteries of diabetic mice lacking the G-protein Gα11,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-93
1422,Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-92
1423,Carotid and cerebrovascular disease in symptomatic patients with type 2 diabetes: assessment of prevalence and plaque morphology by dual-source computed tomography angiography,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-91
1424,Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-90
1425,Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-89
1426,log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-88
1427,High-sensitivity c-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-87
1428,Increased levels of the calcification marker Matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-86
1429,Insulin resistance and circadian rhythm of cardiac autonomic modulation,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-85
1430,New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-84
1431,Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-83
1432,Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-82
1433,Daily steps are low year-round and dip lower in fall/winter: findings from a longitudinal diabetes cohort,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-81
1434,Comparison of the diagnostic performance of 64-slice computed tomography coronary angiography in diabetic and non-diabetic patients with suspected coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-80
1435,GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-79
1436,Hemodynamic and autonomic response to acute hemorrhage in streptozotocin-induced diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-78
1437,Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-77
1438,"Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-76
1439,Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-75
1440,Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-74
1441,Palmitate and insulin synergistically induce IL-6 expression in human monocytes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-73
1442,Intense exercise training induces adaptation in expression and responsiveness of cardiac β-adrenoceptors in diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-72
1443,Eight week exposure to a high sugar high fat diet results in adiposity gain and alterations in metabolic biomarkers in baboons (Papio hamadryas sp.),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-71
1444,"Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-70
1445,"Fibrinogen and associated risk factors in a high-risk population: urban indigenous australians, the druid Study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-69
1446,Uncoupling protein 2 G(-866)A polymorphism: a new gene polymorphism associated with C-reactive protein in type 2 diabetic patients C-reactive protein in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-68
1447,The beneficial effects of exercise in rodents are preserved after detraining: a phenomenon unrelated to GLUT4 expression,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-67
1448,Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-66
1449,Early alterations in vascular contractility associated to changes in fatty acid composition and oxidative stress markers in perivascular adipose tissue,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-65
1450,PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-64
1451,Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-63
1452,The ubiquitous interleukin-6: a time for reappraisal,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-62
1453,Circadian blood pressure variability in type 1 diabetes subjects and their nondiabetic siblings - influence of erythrocyte electron transfer,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-61
1454,Renal protection in diabetes: lessons from ONTARGET®,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-60
1455,Prediction model for high glycated hemoglobin concentration among ethnic Chinese in Taiwan,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-59
1456,Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-58
1457,Lack of effects of pioglitazone on cardiac function in patients with type 2 diabetes and evidence of left ventricular diastolic dysfunction: a tissue doppler imaging study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-57
1458,Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-56
1459,Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-55
1460,Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-54
1461,Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-53
1462,Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-52
1463,Metabolic memory: a vascular perspective,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-51
1464,"Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-50
1465,Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-49
1466,Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-48
1467,Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-47
1468,Intracellular molecular effects of insulin resistance in patients with metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-46
1469,Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-45
1470,Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-44
1471,Oxidant-NO dependent gene regulation in dogs with type I diabetes: impact on cardiac function and metabolism,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-43
1472,Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-42
1473,Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-41
1474,Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-40
1475,Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-39
1476,Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-38
1477,Relationship between blood glucose and carotid intima media thickness: A meta-analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-37
1478,Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-36
1479,KCNQ1 gene polymorphisms are associated with lipid parameters in a Chinese Han population,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-35
1480,Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-34
1481,Chromosome 9p21.3 polymorphism in a Chinese Han population is associated with angiographic coronary plaque progression in non-diabetic but not in type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-33
1482,"The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-32
1483,Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-31
1484,The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-30
1485,Impact of Body Mass Index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-29
1486,The combined effects of sidestream smoke extracts and glycated serum albumin on endothelial cells and platelets,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-28
1487,Hyperinsulinemia improves ischemic LV function in insulin resistant subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-27
1488,Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-26
1489,Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-25
1490,"""If it ain't broke, don't fix it"": a commentary on the positive-negative results of the ACCORD Lipid study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-24
1491,The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-23
1492,Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-22
1493,Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-21
1494,"Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-20
1495,Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-19
1496,"The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-18
1497,"Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-17
1498,"Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-16
1499,Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-15
1500,Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-14
1501,PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-13
1502,Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-12
1503,The role of interleukin-18 in the metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-11
1504,Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-10
1505,"Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-9
1506,Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-8
1507,Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-7
1508,"Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-6
1509,"Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-5
1510,Outcomes in a diabetic population of south Asians and whites following hospitalization for acute myocardial infarction: a retrospective cohort study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-4
1511,Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-3
1512,Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-2
1513,Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-9-1
1514,"Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabetic mice",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-65
1515,Lipogenesis in arterial wall and vascular smooth muscular cells: regulation and abnormalities in insulin-resistance,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-64
1516,Mutations in the coding regions of the hepatocyte nuclear factor 4 alpha in Iranian families with maturity onset diabetes of the young,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-63
1517,Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-62
1518,YKL-40 - an emerging biomarker in cardiovascular disease and diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-61
1519,Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-60
1520,Cardiovascular risk factors in Assyrians/Syrians and native Swedes with type 2 diabetes: a population-based epidemiological study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-59
1521,Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-58
1522,Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-57
1523,Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-56
1524,Elevated resting heart rate is associated with the metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-55
1525,"Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study)",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-54
1526,"Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-53
1527,Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-52
1528,Blood pressure control and components of the metabolic syndrome: the GOOD survey,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-51
1529,MMP-1 serum levels predict coronary atherosclerosis in humans,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-50
1530,"Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-49
1531,Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-48
1532,Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-47
1533,Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-46
1534,Association between carotid diameter and the advanced glycation endproduct Nε-Carboxymethyllysine (CML),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-45
1535,"Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-44
1536,Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-43
1537,Different modulation by dietary restriction of adipokine expression in white adipose tissue sites in the rat,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-42
1538,The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-41
1539,"Lay media reporting of rosiglitazone risk: extent, messaging and quality of reporting",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-40
1540,Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-39
1541,A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-38
1542,Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-37
1543,A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-36
1544,Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-35
1545,Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-34
1546,Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-33
1547,Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-32
1548,The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-31
1549,"Changes in body mass index, leptin and adiponectin in Japanese children during a three-year follow-up period: a population-based cohort study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-30
1550,Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-29
1551,A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-27
1552,Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-26
1553,Patterns and predictors of statin prescription in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-25
1554,Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-24
1555,Postprandial hyperglycemia as an etiological factor in vascular failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-23
1556,Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-22
1557,Associations of cardiovascular risk factors in Al Ain- United Arab Emirates,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-21
1558,Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-20
1559,Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-19
1560,"Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-18
1561,The impact of diabetes on coronary heart disease differs from that on ischaemic stroke with regard to the gender,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-17
1562,Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-16
1563,"Effect of pioglitazone versus insulin glargine on cardiac size, function, and measures of fluid retention in patients with type 2 diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-15
1564,"ACE I/D genotype, adiposity, and blood pressure in children",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-14
1565,Weight control behaviors in overweight/obese U.S. adults with diagnosed hypertension and diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-13
1566,Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-12
1567,Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-11
1568,Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-10
1569,Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-9
1570,The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-8
1571,"Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-7
1572,Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-6
1573,Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-5
1574,Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-4
1575,Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-3
1576,Ethnic differences in cardiometabolic risk profile in an overweight/obese paediatric cohort in the Netherlands: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-2
1577,Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-8-1
1578,Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-36
1579,Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-35
1580,Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-34
1581,Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-33
1582,Improved survival in both men and women with diabetes between 1980 and 2004 – a cohort study in Sweden,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-32
1583,"Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-31
1584,Are the adverse effects of glitazones linked to induced testosterone deficiency?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-30
1585,The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-29
1586,Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-28
1587,Metabolic syndrome according to different definitions in a rapidly developing country of the African region,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-27
1588,Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-26
1589,Anaemia and kidney dysfunction in Caribbean Type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-25
1590,Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-24
1591,"Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-23
1592,"First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-22
1593,The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 × 2 factorial understanding risk trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-21
1594,Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-20
1595,Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-19
1596,Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-18
1597,On the use of a continuous metabolic syndrome score in pediatric research,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-17
1598,Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-16
1599,Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-15
1600,Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-14
1601,Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-14
1602,Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-13
1603,"Treatment with pioglitazone induced significant, reversible mitral regurgitation",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-12
1604,"Diabetic retinopathy is associated with pulse wave velocity, not with the augmentation index of pulse waveform",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-11
1605,Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-10
1606,Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-9
1607,In vivo endothelial gene regulation in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-8
1608,Genetic and dietary salt contributors to insulin resistance in Dahl salt-sensitive (S) rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-7
1609,Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-6
1610,Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-5
1611,Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-4
1612,Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-3
1613,Diacylglycerol kinase ζ inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-2
1614,Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-7-1
1615,The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-39
1616,Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-38
1617,Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients – the Hong Kong diabetes registry,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-37
1618,Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-36
1619,The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-35
1620,Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-34
1621,Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-33
1622,Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-32
1623,Waist circumference does not predict circulating adiponectin levels in sub-Saharan women,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-31
1624,Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-30
1625,The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-29
1626,Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-28
1627,Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-27
1628,Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-26
1629,Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-25
1630,The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-24
1631,Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-23
1632,Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-22
1633,Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-21
1634,Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-20
1635,'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-19
1636,Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-18
1637,Exacerbation of acidosis during ischemia and reperfusion arrhythmia in hearts from type 2 Diabetic Otsuka Long-Evans Tokushima Fatty rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-17
1638,Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-16
1639,Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-15
1640,Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-14
1641,Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-13
1642,"Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-12
1643,Clinical and medication profiles stratified by household income in patients referred for diabetes care,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-11
1644,Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-10
1645,Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-9
1646,Pro-oxidant effect of α-tocopherol in patients with Type 2 Diabetes after an oral glucose tolerance test – a randomised controlled trial,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-8
1647,"Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-7
1648,Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-6
1649,Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-5
1650,Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-4
1651,Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-3
1652,Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-2
1653,Walking behaviour and glycemic control in type 2 diabetes: seasonal and gender differences-Study design and methods,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-6-1
1654,Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-27
1655,Myocardial performance in conscious streptozotocin diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-26
1656,"The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-25
1657,Moderate ischemic mitral regurgitation (IMR) and metabolic syndrome: where are we now and where are we going?,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-24
1658,Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-23
1659,Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-22
1660,Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-21
1661,Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-20
1662,Hyperglycemia and nocturnal systolic blood pressure are associatedwith left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-19
1663,Diabetes alters vascular mechanotransduction: pressure-induced regulation of mitogen activated protein kinases in the rat inferior vena cava,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-18
1664,"Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-17
1665,Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study),http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-16
1666,Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-15
1667,"Plasma levels of soluble tumor necrosis factor-α receptors are related to total and LDL-cholesterol in lean, but not in obese subjects",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-14
1668,Insulin and glucose play a role in foam cell formation and function,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-13
1669,"Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-12
1670,Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-11
1671,Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in south-Asians,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-10
1672,Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-9
1673,Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-8
1674,Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-7
1675,Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-6
1676,Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-5
1677,Endothelial dysfunction: a comprehensive appraisal,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-4
1678,Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: Relation to vessel size,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-3
1679,Cardio-protective effects of carnitine in streptozotocin-induced diabetic rats,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-2
1680,Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-5-1
1681,Prevalence of antiplatelet therapy in patients with diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-18
1682,Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-17
1683,Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-16
1684,Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-15
1685,Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-14
1686,Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481],http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-13
1687,"Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-12
1688,Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-11
1689,Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-10
1690,The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-9
1691,Statins research unfinished saga: desirability versus feasibility,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-8
1692,Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-7
1693,Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-6
1694,Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-5
1695,"Vascular ossification – calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis – calcific uremic arteriolopathy: the emerging role of sodium thiosulfate",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-4
1696,Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-3
1697,Saturated free fatty acids and apoptosis in microvascular mesangial cells: palmitate activates pro-apoptotic signaling involving caspase 9 and mitochondrial release of endonuclease G,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-2
1698,Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review,http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-4-1
1699,"Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?",http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-3-10
1700,The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481],http://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-3-9
